Group 1 - Tianyi Medical's stock price dropped by 3.48% on January 22, with a trading volume of 90.75 million yuan. The financing buy amount was 8.55 million yuan, while the financing repayment was 6.45 million yuan, resulting in a net financing buy of 2.09 million yuan. The total financing and securities balance reached 58.82 million yuan as of January 22, which is 1.71% of the circulating market value and is at a high level compared to the past year [1] - The company specializes in the research, production, and sales of medical devices related to blood purification and ward care, with revenue composition being 59.05% from blood purification, 34.08% from ward care, and 6.87% from other sources [1] - As of December 10, the number of shareholders for Tianyi Medical was 5,135, a decrease of 1.36% from the previous period. The average circulating shares per person increased by 1.38% to 5,637 shares [2] Group 2 - For the period from January to September 2025, Tianyi Medical achieved an operating income of 387 million yuan, representing a year-on-year growth of 24.14%. The net profit attributable to the parent company was 20.09 million yuan, showing a significant year-on-year increase of 216.81% [2] - Since its A-share listing, Tianyi Medical has distributed a total of 102 million yuan in dividends, with 87.50 million yuan distributed over the past three years [3] - As of September 30, 2025, among the top ten circulating shareholders, Penghua Hongjia Mixed A held 498,700 shares, remaining unchanged from the previous period, while CITIC Prudential Multi-Strategy Mixed A entered the list as the tenth largest shareholder with 207,900 shares [3]
天益医疗1月22日获融资买入854.51万元，融资余额5881.74万元